TrakCel announces formation of Advisory board
TrakCel today announced the formation of its Advisory board. Each Advisory Board member offers highly specialised knowledge and strategic and operational expertise in support of TrakCel’s ongoing development. Their experience and expertise reflects our focus, our international aspirations and augments our internal resources to achieve our vision of creating a World-class technology company.
TrakCel’s patented technology is a single solution for controlling cell therapy processes from start to finish, to help assure patient safety, enable efficient clinical study and supply chain scale-up, provide multi-site standardisation and help drive clinical adoption. The technology provides instructions to professionals in the cell therapy process, and gives stakeholders visibility of all activities in the advanced therapy medicinal products (ATMP) supply chain from patient registration and collection of cells, through logistics, storage, processing of the cells in manufacturing and return delivery to the patient. Founded in 2012, TrakCel is based in Cardiff, Wales, UK.
For more information on the TrakCel Advisory Board, or to find out how you can take part and offer feedback get in touch with our team today.
Article by TrakCel Marketing Team - 19 May 2014